id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-3208-0004,FDA,FDA-2022-N-3208,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2023-10-11T04:00:00Z,2023,10,2023-10-11T04:00:00Z,,2023-10-11T14:11:31Z,2023-22465,0,0,09000064860a7f3c
FDA-2022-N-3208-0003,FDA,FDA-2022-N-3208,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; Records and Reports Concerning Experiences With Approved New Animal Drugs: Adverse Event Reports",Notice,30 Day Proposed Information Collection,2023-04-28T04:00:00Z,2023,4,2023-04-28T04:00:00Z,2023-05-31T03:59:59Z,2023-04-28T14:26:42Z,2023-08999,0,0,090000648599b0d8
FDA-2022-N-3208-0001,FDA,FDA-2022-N-3208,Agency Information Collection Activities; Proposed Collection; Comment Request; Records and Reports Concerning Experiences With Approved New Animal Drugs: Adverse Event Reports,Notice,60 Day Proposed Information Collection,2022-12-22T05:00:00Z,2022,12,2022-12-22T05:00:00Z,2023-02-22T04:59:59Z,2022-12-24T02:01:01Z,2022-27817,0,0,090000648554d3b5